Anti-wrinkle composition

Details Anti-wrinkle composition Anti-wrinkle composition

2007-01-17

2010-10-05

Clark, Amy L (Department: 1655)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

C424S725000, C424S401000, C514S001000

Reexamination Certificate

active

07807625

ABSTRACT:
A composition is disclosed for treating the skin comprising an acylated short chain bioactive peptide andLycium barbarumextract product. Also disclosed is a method for topically administering the composition in an amount therapeutically effective to reduce wrinkles by building the dermal fibroblast matrix. The composition may contain dimethylisosorbide or ethoxydiglycol as solubilizing and penetration enhancers for the hydrophobically modified peptide.

REFERENCES:
patent: 4814173 (1989-03-01), Song et al.
patent: 4880630 (1989-11-01), Novak
patent: 5902591 (1999-05-01), Herstein
patent: 6194452 (2001-02-01), Murad
patent: 6875744 (2005-04-01), Owen
patent: 6974799 (2005-12-01), Lintner
patent: 2004/0147443 (2004-07-01), Renault
patent: 2005/0148495 (2005-07-01), Lambert, Jr. et al.
patent: 2002138045 (2002-05-01), None
Zhao et al. “Lycium barbarum glycoconjugates: effect on human skin and cultured dermal fibroblasts”. Phytomedicine, vol. 12, No. 1-2 (2005):131-137, PubMed Abstract only..
Phytomedicine 12 (2005) pp. 131-137; H. Zhao et al; www.sciencedirect.com; Lycium barbarum glycoconjugates: . . . .

Affiliated with

Also associated with

Rating

Anti-wrinkle composition does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Anti-wrinkle composition, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anti-wrinkle composition will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4230274